Your browser doesn't support javascript.
loading
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Jordan, Chloe J; Cao, Jianjing; Newman, Amy Hauck; Xi, Zheng-Xiong.
Affiliation
  • Jordan CJ; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, 21224, USA.
  • Cao J; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, 21224, USA.
  • Newman AH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, 21224, USA.
  • Xi ZX; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, 21224, USA. Electronic address: zxi@mail.nih.gov.
Neuropharmacology ; 158: 107609, 2019 11 01.
Article in En | MEDLINE | ID: mdl-31009632
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine Uptake Inhibitors / Cocaine-Related Disorders / Opiate Substitution Treatment / Analgesics, Opioid / Opioid-Related Disorders Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neuropharmacology Year: 2019 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine Uptake Inhibitors / Cocaine-Related Disorders / Opiate Substitution Treatment / Analgesics, Opioid / Opioid-Related Disorders Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neuropharmacology Year: 2019 Document type: Article Affiliation country: United States